Celcuity (CELC) Competitors $10.80 -0.34 (-3.05%) Closing price 04:00 PM EasternExtended Trading$10.78 -0.02 (-0.19%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELC vs. NHC, PACS, TDOC, VRDN, AHCO, CDNA, GRAL, PNTG, AVAH, and CSTLShould you be buying Celcuity stock or one of its competitors? The main competitors of Celcuity include National HealthCare (NHC), PACS Group (PACS), Teladoc Health (TDOC), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), CareDx (CDNA), Grail (GRAL), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), and Castle Biosciences (CSTL). These companies are all part of the "healthcare" industry. Celcuity vs. National HealthCare PACS Group Teladoc Health Viridian Therapeutics AdaptHealth CareDx Grail The Pennant Group Aveanna Healthcare Castle Biosciences National HealthCare (NYSE:NHC) and Celcuity (NASDAQ:CELC) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, community ranking, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations. Which has more volatility & risk, NHC or CELC? National HealthCare has a beta of 0.42, meaning that its stock price is 58% less volatile than the S&P 500. Comparatively, Celcuity has a beta of 0.44, meaning that its stock price is 56% less volatile than the S&P 500. Do insiders & institutionals believe in NHC or CELC? 56.4% of National HealthCare shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 15.0% of National HealthCare shares are held by company insiders. Comparatively, 15.8% of Celcuity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is NHC or CELC more profitable? National HealthCare has a net margin of 10.03% compared to Celcuity's net margin of 0.00%. National HealthCare's return on equity of 6.87% beat Celcuity's return on equity.Company Net Margins Return on Equity Return on Assets National HealthCare10.03% 6.87% 4.68% Celcuity N/A -62.66%-39.78% Does the MarketBeat Community prefer NHC or CELC? Celcuity received 338 more outperform votes than National HealthCare when rated by MarketBeat users. However, 100.00% of users gave National HealthCare an outperform vote while only 67.79% of users gave Celcuity an outperform vote. CompanyUnderperformOutperformNational HealthCareOutperform Votes3100.00% Underperform VotesNo VotesCelcuityOutperform Votes34167.79% Underperform Votes16232.21% Which has higher valuation and earnings, NHC or CELC? National HealthCare has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than National HealthCare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNational HealthCare$1.30B1.11$66.80M$6.5414.26CelcuityN/AN/A-$63.78M-$2.81-3.90 Does the media refer more to NHC or CELC? In the previous week, Celcuity had 4 more articles in the media than National HealthCare. MarketBeat recorded 6 mentions for Celcuity and 2 mentions for National HealthCare. National HealthCare's average media sentiment score of 1.62 beat Celcuity's score of 1.36 indicating that National HealthCare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National HealthCare 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Celcuity 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer NHC or CELC? Celcuity has a consensus target price of $30.17, indicating a potential upside of 175.60%. Given Celcuity's stronger consensus rating and higher probable upside, analysts clearly believe Celcuity is more favorable than National HealthCare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score National HealthCare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Celcuity 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14 SummaryNational HealthCare and Celcuity tied by winning 9 of the 18 factors compared between the two stocks. Get Celcuity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELC vs. The Competition Export to ExcelMetricCelcuityMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$413.20M$2.89B$5.50B$7.96BDividend YieldN/A31.29%5.11%4.23%P/E Ratio-4.1813.0722.6318.55Price / SalesN/A189.00397.30103.38Price / CashN/A57.5638.1834.62Price / Book2.004.696.704.25Net Income-$63.78M-$22.21M$3.23B$248.27M7 Day Performance-0.85%-2.34%1.36%1.28%1 Month Performance17.83%2.61%3.85%3.75%1 Year Performance-32.85%10.54%15.87%5.31% Celcuity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELCCelcuity2.6347 of 5 stars$10.80-3.1%$30.17+179.3%-29.4%$408.66MN/A-4.1440Short Interest ↓Analyst RevisionPositive NewsNHCNational HealthCareN/A$90.31-2.0%N/AN/A$1.40B$1.30B11.3212,400Positive NewsPACSPACS Group3.3629 of 5 stars$8.58-7.3%$34.00+296.3%-61.5%$1.31B$3.56B0.0032,433Positive NewsTDOCTeladoc Health3.8067 of 5 stars$6.52-4.5%$10.82+66.0%-43.8%$1.14B$2.57B-1.135,100Analyst ForecastNews CoverageVRDNViridian Therapeutics1.2571 of 5 stars$13.13flat$35.70+171.9%+2.2%$1.07B$302,000.00-3.0550Upcoming EarningsNews CoveragePositive NewsAHCOAdaptHealth3.4489 of 5 stars$7.33-5.9%$13.80+88.3%-13.6%$988.58M$3.26B-4.4410,900Upcoming EarningsCDNACareDx3.4773 of 5 stars$16.94-3.9%$30.33+79.1%+117.5%$938.92M$333.79M-6.27740Earnings ReportNews CoverageGap DownGRALGrail0.6284 of 5 stars$26.42-2.1%$26.00-1.6%N/A$932.55M$125.60M0.001,360Positive NewsPNTGThe Pennant Group3.1681 of 5 stars$24.50-6.2%$34.80+42.0%+22.5%$850.69M$695.24M36.035,340Upcoming EarningsNews CoveragePositive NewsAVAHAveanna Healthcare0.9797 of 5 stars$4.22-7.0%$5.00+18.5%+104.9%$823.30M$2.02B-12.4133,000Upcoming EarningsNews CoverageCSTLCastle Biosciences3.0659 of 5 stars$21.14-1.7%$38.75+83.3%-4.9%$609.78M$332.07M105.71540Upcoming Earnings Related Companies and Tools Related Companies National HealthCare Competitors PACS Group Competitors Teladoc Health Competitors Viridian Therapeutics Competitors AdaptHealth Competitors CareDx Competitors Grail Competitors The Pennant Group Competitors Aveanna Healthcare Competitors Castle Biosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELC) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celcuity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Celcuity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.